Research Article
Key CMM Combinations in Prescriptions for Treating Mastitis and Working Mechanism Analysis Based on Network Pharmacology
Table 3
Targets related to mastitis disease.
| Symbol | Description | Score |
| LTF | Lactotransferrin | 27.2 | CXCL8 | C-X-C Motif Chemokine Ligand 8 | 23.43 | TLR2 | Toll Like Receptor 2 | 23.13 | IL6 | Interleukin 6 | 22.28 | LBP | Lipopolysaccharide Binding Protein | 22.18 | ALB | Albumin | 22.16 | CCL5 | C-C Motif Chemokine Ligand 5 | 21.49 | NOD2 | Nucleotide Binding Oligomerization Domain Containing 2 | 21.14 | IL17A | Interleukin 17A | 20.81 | HP | Haptoglobin | 20.74 | CP | Ceruloplasmin | 20.69 | CSF2 | Colony Stimulating Factor 2 | 20.01 | ICAM1 | Intercellular Adhesion Molecule 1 | 19.99 | CSN2 | Casein Beta | 13.66 | LALBA | Lactalbumin Alpha | 12.71 | OXT | Oxytocin/Neurophysin I Prepropeptide | 12.49 | CXCL6 | C-X-C Motif Chemokine Ligand 6 | 11.6 | CSN3 | Casein Kappa | 11.3 | SLPI | Secretory Leukocyte Peptidase Inhibitor | 11.2 | STAT5A | Signal Transducer And Activator Of Transcription 5A | 10.48 |
|
|